
Lakshmi Sarada Channavajjala
Examiner (ID: 456, Phone: (571)272-0591 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1615, 1611 |
| Total Applications | 1737 |
| Issued Applications | 722 |
| Pending Applications | 210 |
| Abandoned Applications | 818 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17944237
[patent_doc_number] => 20220331254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => PELLET AND MULTI-UNIT PELLET SYSTEM (MUPS)
[patent_app_type] => utility
[patent_app_number] => 17/856817
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856817
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856817 | PELLET AND MULTI-UNIT PELLET SYSTEM (MUPS) | Jun 30, 2022 | Abandoned |
Array
(
[id] => 17928223
[patent_doc_number] => 20220323348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => LOZENGE
[patent_app_type] => utility
[patent_app_number] => 17/809288
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/809288 | LOZENGE | Jun 27, 2022 | Abandoned |
Array
(
[id] => 18257968
[patent_doc_number] => 20230085008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF MIFEPRISTONE
[patent_app_type] => utility
[patent_app_number] => 17/843669
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843669
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/843669 | Pharmaceutical compositions of mifepristone | Jun 16, 2022 | Issued |
Array
(
[id] => 20577208
[patent_doc_number] => 12569443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Gastro-retentive drug delivery system
[patent_app_type] => utility
[patent_app_number] => 17/833979
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 8720
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833979
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833979 | Gastro-retentive drug delivery system | Jun 6, 2022 | Issued |
Array
(
[id] => 17836268
[patent_doc_number] => 20220273573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => SOLID DISPERSION GENISTEIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/664015
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17664015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/664015 | SOLID DISPERSION GENISTEIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | May 17, 2022 | Pending |
Array
(
[id] => 20270699
[patent_doc_number] => 12440463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Modified release orally administered amino acid formulations
[patent_app_type] => utility
[patent_app_number] => 17/660999
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 19
[patent_no_of_words] => 17265
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/660999 | Modified release orally administered amino acid formulations | Apr 26, 2022 | Issued |
Array
(
[id] => 20676397
[patent_doc_number] => 20260115206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-30
[patent_title] => 3Alpha-OH-5Alpha-Pregnan-20-One Compositions and Methods for Treating CNS Disorders
[patent_app_type] => utility
[patent_app_number] => 17/723203
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723203
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/723203 | 3Alpha-OH-5Alpha-Pregnan-20-One Compositions and Methods for Treating CNS Disorders | Apr 17, 2022 | Pending |
Array
(
[id] => 17747411
[patent_doc_number] => 20220225614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC DISINFECTANT COMPOSITIONS HAVING ENHANCED ANTIMICROBIAL EFFICACY AND STABILITY, AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/714178
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714178
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714178 | Synergistic disinfectant compositions having enhanced antimicrobial efficacy and stability, and methods of using the same | Apr 5, 2022 | Issued |
Array
(
[id] => 17895297
[patent_doc_number] => 20220304959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => TREATMENT OF LONG HAULERS SYNDROME WITH NICLOSAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/703626
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/703626 | TREATMENT OF LONG HAULERS SYNDROME WITH NICLOSAMIDE | Mar 23, 2022 | Abandoned |
Array
(
[id] => 18483633
[patent_doc_number] => 20230210934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => LYCIUM BARBARUM LEAF POLYSACCHARIDE RICH IN GALACTURONIC ACID AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/652210
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/652210 | LYCIUM BARBARUM LEAF POLYSACCHARIDE RICH IN GALACTURONIC ACID AND PREPARATION METHOD AND USE THEREOF | Feb 22, 2022 | Abandoned |
Array
(
[id] => 20525998
[patent_doc_number] => 12544417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Oral film and stick jelly for improving absorption in the oral mucosa, antioxidant activity, anti-inflammatory activity, and liver function of humans and companion animals
[patent_app_type] => utility
[patent_app_number] => 17/769051
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6942
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769051 | Oral film and stick jelly for improving absorption in the oral mucosa, antioxidant activity, anti-inflammatory activity, and liver function of humans and companion animals | Feb 16, 2022 | Issued |
Array
(
[id] => 20401268
[patent_doc_number] => 12491228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Fine bamboo powder and preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/589963
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 14381
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/589963 | Fine bamboo powder and preparation method therefor and use thereof | Jan 31, 2022 | Issued |
Array
(
[id] => 18244372
[patent_doc_number] => 20230076683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Controlled Release Formulations and Methods of Targeted Drug Delivery within the Small Intestine Wall
[patent_app_type] => utility
[patent_app_number] => 17/562899
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562899
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/562899 | Controlled Release Formulations and Methods of Targeted Drug Delivery within the Small Intestine Wall | Dec 26, 2021 | Abandoned |
Array
(
[id] => 17532306
[patent_doc_number] => 20220110915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/560493
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560493 | Edaravone suspension for oral administration | Dec 22, 2021 | Issued |
Array
(
[id] => 19700150
[patent_doc_number] => 12194150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Levodopa dosing regimen
[patent_app_type] => utility
[patent_app_number] => 17/558337
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 39730
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558337
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558337 | Levodopa dosing regimen | Dec 20, 2021 | Issued |
Array
(
[id] => 17519216
[patent_doc_number] => 20220105064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
[patent_app_type] => utility
[patent_app_number] => 17/553367
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553367 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | Dec 15, 2021 | Abandoned |
Array
(
[id] => 18842668
[patent_doc_number] => 20230405072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => Texture-Controlled Fiber Ingredient Containing Viscous Soluble Fiber and Consumable Food and Fiber Supplement Products Incorporating Same
[patent_app_type] => utility
[patent_app_number] => 18/037611
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037611 | Texture-Controlled Fiber Ingredient Containing Viscous Soluble Fiber and Consumable Food and Fiber Supplement Products Incorporating Same | Nov 18, 2021 | Pending |
Array
(
[id] => 18842664
[patent_doc_number] => 20230405068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => RADIATION-INDUCED FIBROSIS TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/035432
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035432
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035432 | RADIATION-INDUCED FIBROSIS TREATMENT | Nov 7, 2021 | Pending |
Array
(
[id] => 19622972
[patent_doc_number] => 12161764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Composition and methods of treatment
[patent_app_type] => utility
[patent_app_number] => 17/512139
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 8398
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512139 | Composition and methods of treatment | Oct 26, 2021 | Issued |
Array
(
[id] => 17881112
[patent_doc_number] => 20220296589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same
[patent_app_type] => utility
[patent_app_number] => 17/509965
[patent_app_country] => US
[patent_app_date] => 2021-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17509965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/509965 | Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same | Oct 24, 2021 | Abandoned |